-
-
-
-
-
-
-
Quest Diagnostics integrates cancer tests into Flatiron's OncoEMR platform
-
-
-
-
-
-
-
Quest Diagnostics (DGX) PT Raised to $230 at Barclays
-
-
-
-
-
-
-
Quest Diagnostics appoints Benjamin Beauvalot as strategy and M&A chief
-
-
-
-
-
-
-
Quest Diagnostics (DGX) Declares $0.8 Quarterly Dividend; 1.7% Yield
-
-
-
-
-
-
-
Mass General Brigham launches clinical trials for Haystack MRD cancer test
-
-
-
-
-
-
-
Redburn-Atlantic Starts Quest Diagnostics (DGX) at Buy
-
-
-
-
-
-
-
Quest Diagnostics (DGX) PT Raised to $190 at Jefferies
-
464,971 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

